We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Speaker: Aldo Di Vito, predoctoral researcher Translational Molecular Pathology (VHIR)
Metastasis, the process through which tumor cells can colonize distant tissues, represents the leading cause of cancer-related death, including in Gastrointestinal stromal tumors (GISTs). Even if metastasis is considered a promising target for pharmaceutical research, the molecular events behind GIST metastasis remain poorly known. Vargas-Accarino and colleagues (2021) have recently reported that certain adherent cell lines can give rise to floating but living cells in vitro by spontaneous detachment. These cells can newly re-attach and grow if seeded in a new plate, thus partially mimicking features of the metastatic cascade in vitro. We first observed that adherent metastatic GIST-T1 (unlike non-metastatic GIST-882 and GIST-48 lines), releases a small floating subpopulation that can similarly colonize a new cell culture plate. We are using this system as an in vitro model of GIST metastasis, in combination with proteomics analysis, in order to unveil the mechanisms that regulate the transition between adherent, floating, and re-adherent cells. Summary of the in vitro “metastatic-like” process. “Metastatic-like” subclones activate an own and medium independent transition, detaching and becoming floating (detachment). Then, as demonstrated, they can survive (surviving) as floating cells and re-attach in a new dish assisted by the presence of fresh medium (re-attachment).
Short CV description: I got my bachelor’s degree in biotechnologies sciences and my master’s degree in Pharmaceutical Biotechnologies at the University Federico II of Naples. Then I joined the R&D department of Bracco Imaging SpA and I worked as junior scientist for about five years. I am currently a PhD student in the Department of Pharmacology and Biotechnology at the University of Bologna. As Visiting Ph.D. Student I have recently joined the Translational Molecular Pathology laboratory here at Vall d’Hebron Institut de Recerca (VHIR), under the supervision of Dr. Trond Aasen. I have worked in the field of cancer research since the beginning of my career, being involved in projects focused on identifying novel diagnostic probes, therapeutic compounds and studying in vitro cancer metastasis.
Host: Dr. Trond Aasen, Main researcher, Translational Molecular Pathology (VHIR)
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.